Author:
Kaeser Lisa,Darroch Forrest Jacqueline,Rosenfield Allan
Abstract
AbstractDespite the need for more safe and effective contraceptive drugs and devices, enormous barriers to contraceptive research and development have been raised in the United States. The designation of contraceptives as orphan drugs, with concomitant incentives, may be warranted to encourage private manufacturers to reenter the field.
Publisher
Cambridge University Press (CUP)
Reference17 articles.
1. 16.P.L. 97–414 Sec. 5(a) 1983.
2. 17. Senate Subcommittee on Labor-Health and Human Services-Education. Committee report on H. R. 5257, Appropriations for Fiscal Year 1991.
3. Depo-Provera: The Jury Still Out
4. Whatever Happened to the Contraceptive Revolution?
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献